Hyperfractionation in radiation treatment of advanced head and neck cancer. A preliminary report.
The effects and side-effects of hyperfractionated therapy in advanced head and neck cancer were investigated in a prospective study. The data of 71 patients were available for evaluation and these were compared to a historical control group treated by a standard one-day fractionation schedule; they showed a tendency to local superiority of hyperfractionated irradiation.